Listed by the USPTO as BUNKER, AMY M
Tech Center 1600 • Art Units: 1612 1625 1634 1639 1675 1684
This examiner grants 29% of resolved cases
This examiner is in Tech Center 1600 and Art Unit 1612, with 514 resolved cases. The allowance rate is 29.0%, and the median time to allowance is 1427 days. The 45.1% interview lift is a strong positive signal against a low overall allowance rate, indicating that interviews may be especially useful when substantive issues are clearly framed.
The principal companies are The Regents of the University of California, Bio-Rad Laboratories Inc., and University of Washington. The leading firms are DAMBROSIO & MENON, P.L.L.C., Jones Day, and LEYDIG VOIT & MAYER, LTD. Practitioners should expect a demanding record but may improve case positioning by using interviews alongside technically supported amendments and evidence.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18657366 | Methods of Producing Size-Selected Nucleic Acid Libraries and Compositions and Kits for Practicing Same | Non-Final OA | The Regents of the University of California |
| 17911509 | SINGLE-CELL COMBINATORIAL INDEXED CYTOMETRY SEQUENCING | Final Rejection | The Regents of the University of California |
| 18235015 | FC-RECEPTOR BASED AFFINITY CHROMATOGRAPHY | Non-Final OA | Hoffmann-La Roche Inc. |
| 18550004 | HIGH THROUGHOUT SCREENING IN DROPLETS | Final Rejection | Novartis AG |
| 17938254 | Polynucleotide Barcodes for Multiplexed Proteomics | Final Rejection | Singular Genomics Systems, Inc. |
| 18256877 | METHODS FOR SEQUENCING POLYNUCLEOTIDE FRAGMENTS FROM BOTH ENDS | Final Rejection | Agilent Technologies, Inc. |
| 18374492 | MASS SPECTROMETRY-BASED STRATEGY FOR DETERMINING PRODUCT-RELATED VARIANTS OF A BIOLOGIC | Final Rejection | Regeneron Pharmaceuticals, Inc. |
| 16936197 | FUNCTIONALIZED SOLID SUPPORT | Non-Final OA | Massachusetts Institute of Technology |
| 18235205 | HIGH EFFICIENCY, SMALL VOLUME NUCLEIC ACID SYNTHESIS | Non-Final OA | LIFE TECHNOLOGIES CORPORATION |
| 18297137 | METHODS AND COMPOSITIONS FOR ANALYZING ANTIGEN BINDING MOLECULES | Non-Final OA | 10x Genomics, Inc. |
| 18035269 | METHODS FOR IDENTIFYING DRIVERS OF IMMUNE RESPONSES USING MOLECULAR EXPRESSION SIGNATURES OF IMMUNOMODULATING AGENTS | Final Rejection | The General Hospital Corporation |
| 17785762 | NUCLEIC ACID ANALYSIS METHODS AND APPARATUS | Non-Final OA | BASF SE |
| 18381400 | METHODS AND COMPOSITIONS FOR TRACKING BARCODES IN PARTITIONS | Non-Final OA | Bio-Rad Laboratories, Inc. |
| 17729760 | SYSTEM AND METHOD FOR ISOLATING AND ANALYZING CELLS | Non-Final OA | Bio-Rad Laboratories, Inc. |
| 17928690 | METHODS AND COMPOSITIONS FOR IN VITRO AFFINITY MATURATION OF MONOCLONAL ANTIBODIES | Final Rejection | University of Southern California |
| 18464846 | COMPOSITIONS AND METHODS OF USE OF SYNTHETIC PEPTIDES WITH MYCOBACTERIUM ABSCESSUS INHIBITORY ACTIVITY | Final Rejection | ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY |
| 18289740 | PARALLEL MULTIPLE DISPLACEMENT AMPLIFICATION METHOD | Non-Final OA | SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION |
| 18285329 | NEXTGEN CHEMOMETRICS USING PROXIMITY LIGATION ASSAY (PLA) | Final Rejection | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM |
| 18695400 | COMPOUND HAVING PHOTOCLEAVABLE MOIETY, CONJUGATE, AND SCREENING METHOD USING SAME | Non-Final OA | CHUGAI SEIYAKU KABUSHIKI KAISHA |
| 17165293 | Affinity Reagent and Catalyst Discovery Through Fiber-Optic Array Scanning Technology | Final Rejection | SRI International |
| 18282206 | SYSTEMS AND METHODS FOR DETERMINING BARCODES AND SCREENING IN SITU | Non-Final OA | YALE UNIVERSITY |
| 18035678 | HAIRPIN OLIGONUCLEOTIDES AND USES THEREOF | Final Rejection | The University of Chicago |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy29.0% of resolved applications examined by Amy M Bunker were allowed (514 resolved cases), compared with 40.6% across Art Unit 1612 over the last five years.
This examiner's interview lift is +45.1 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Amy M Bunker took 1,427 days on average from filing to allowance.
Amy M Bunker examines applications in Art Unit 1612 in Tech Center 1600 (Biotechnology & Pharmaceuticals).